Case Challenge

Management of a Virologically Suppressed Patient Experiencing Injection Site Reactions With His Current Regimen

Source: The Role of Integrase Inhibitors in HIV Management

Management of a Virologically Suppressed Patient Experiencing Injection Site Reactions With His Current Regimen

Faculty:

Jonathan M. Schapiro, MD

CREDIT INFORMATION

Release Date: June 12, 2008

Expiration Date: June 11, 2009

Physicians: maximum of 1.0 AMA PRA Category 1 Credit™

Registered Nurses: 0.9 Nursing contact hours

Status: The activity is not currently available for credit.

Learning Objectives

Upon completion of this activity, participants should be able to:

Describe the current indications for recently approved novel antiretroviral agents
Discuss key factors to be considered in managing a virologically suppressed patient who is experiencing intolerable adverse events
Discuss key factors to be considered in determining viral susceptibility to new agents in switch regimens

Test your ability to make optimal treatment decisions using patient histories and diagnostic information and see the case unfold according to your choices. Compare your answers with your peers and our expert faculty’s recommendations, and then review the supporting data.

Disclaimer: The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.